23 April 2021 – Following President Rodrigo Duterte’s directive to set up a green lane for faster permit processing of local COVID-19 vaccine manufacturers to reduce dependency on imported jabs, Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica urged the Food and Drug Administration (FDA) to target its completion within seven (7) working days. The.. read more
Statement of the Anti-Red Tape Authority on FDA’s Issuance of LTO to Ivermectin Compounder Dr. Allan Landrito
Following our insistent calls to expedite the processing of permit applications, the Anti-Red Tape Authority (ARTA) is pleased to learn that the Food and Drug Administration (FDA) has issued a License to Operate (LTO) for medicine trading to Dr. Allan Landrito, a vocal proponent of using Ivermectin to treat COVID-19. ARTA was informed about this.. read more
Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients
The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more
ARTA to discuss with DOH, FDA the inclusion of Ivermectin in the COVID-19 treatment protocol for emergency use
30 March 2021 – The Anti-Red Tape Authority (ARTA) will discuss the possible inclusion of Ivermectin in the COVID-19 treatment protocol with the Department of Health (DOH) and the Food and Drug Administration (FDA) on its meeting with the said agencies tomorrow, Wednesday. This, after FDA Director General Eric Domingo explained in a meeting earlier.. read more
ARTA to FDA: Expedite application process for Ivermectin
29 March 2021 – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for the possible treatment of COVID-19 symptoms. This, after the FDA announced earlier today that doctors and hospitals may now apply for.. read more